Stocks and Investing
Stocks and Investing
Tue, March 5, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Ami Fadia Maintained (AVDL) at Strong Buy with Increased Target to $22 on, Mar 5th, 2024
Ami Fadia of Needham, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Increased Target from $20 to $22 on, Mar 5th, 2024.
Ami has made no other calls on AVDL in the last 4 months.
There is 1 other peer that has a rating on AVDL. Out of the 1 peers that are also analyzing AVDL, 0 agree with Ami's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ami
- Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $21 on, Tuesday, February 6th, 2024
Contributing Sources